Surface modification and endothelialization of vascular biomaterials are common
approaches that are used to both resist the nonspecific adhesion of proteins and improve …

When blood first encounters the artificial surface of a medical device, a complex series of
biochemical reactions is triggered, potentially resulting in clinical complications such as …

Compared to bare-metal stents (BMSs), drug-eluting stents (DESs) have been regarded as a
revolutionary change in coronary artery diseases (CADs). Releasing pharmaceutical agents …

Device-associated clot formation and poor tissue integration are ongoing problems with
permanent and temporary implantable medical devices. These complications lead to …

Hemocompatibility of biomaterials in contact with the blood of patients is a prerequisite for
the short-and long-term applications of medical devices such as cardiovascular stents …

Cardiovascular implants, especially vascular grafts made of synthetic polymers, find wide
clinical applications in the treatment of cardiovascular diseases. However, cases of failure …

Biomedical devices in the blood flow disturb the fine-tuned balance of pro-and anti-
coagulant factors in blood and vessel wall. Numerous technologies have been suggested to …

Synthetic polymers, particularly polyurethanes (PUs), have revolutionized bioengineering
and biomedical devices due to their customizable mechanical properties and long-term …

Although magnesium alloy has received tremendous attention in biodegradable
cardiovascular stents, the poor in vivo corrosion resistance and limited endothelialization …

Catheter associated thrombosis is an ongoing problem. Omniphobic coatings based on
tethering biocompatible liquid lubricants on self-assembled monolayers of hydrophobic …